449. Sca-1+ Cell-Based Gene Therapy with a Modified Fibroblast Growth Factor 2 (FGF2) Increased Endosteal/Trabecular Bone Formation in Mice

Hall, S. L., Lau, K.-H. W., Chen, S.-T., Sheng, M. H.-C., Srivastava, A. K., Klamut, H. J., … Baylink, D. J. (2006). 449. Sca-1+ Cell-Based Gene Therapy with a Modified Fibroblast Growth Factor 2 (FGF2) Increased Endosteal/Trabecular Bone Formation in Mice. Molecular Therapy, 13, S173. https://doi.org/10.1016/j.ymthe.2006.08.517